| Robert Michael Sheppard, CRNA | |
|
250 West 9th, Hoisington, KS 67544 | |
| (620) 653-2114 | |
| Not Available |
| Full Name | Robert Michael Sheppard |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 250 West 9th, Hoisington, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164494381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 54239 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Michael Sheppard, CRNA Po Box 388, Newton, KS 67114-0388 Ph: (316) 281-3700 | Robert Michael Sheppard, CRNA 250 West 9th, Hoisington, KS 67544 Ph: (620) 653-2114 |
News Archive
Obstructive sleep apnea (OSA) is independently associated with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM), according to a new study from researchers in the UK. The severity of DPN is also correlated with the degree of OSA and the severity of nocturnal hypoxemia.
As scientists across the globe race to develop a vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, an international team led by Davide Corti at Vir Biotechnology and David Veesler at the University of Washington has been working around the clock on a complementary approach - identifying neutralizing antibodies that could be used as a preventative treatment or as a post-exposure therapy.
An estimated 500,000 babies born around the world each year develop unnecessary brain damage that could be treated if caught in time – but monitoring these infants' delicate brains is extremely difficult.
Malaria infection and deaths could be avoided by more than half a million young children thanks to an accelerated regime of preventative drugs being rolled in four African countries, says global health agency Unitaid.
Encore Therapeutics Inc. has developed a proprietary extended release subcutaneous (SC) depot formulation (ETI-511) of the NSAID drug meloxicam.
› Verified 7 days ago
Samuel D Travis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 W 9th St, Hoisington, KS 67544 Phone: 620-653-2114 Fax: 620-653-2350 | |
Matthew Ryan Barlow, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 W 9th St, Hoisington, KS 67544 Phone: 620-653-2114 Fax: 620-653-2350 |